ALN-ANG3

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-ANG3, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults [Phase 1]

See pricing